These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17520443)

  • 21. Formulation and evaluation of fast dissolving tablets of cinnarizine using superdisintegrant blends and subliming material.
    Basu B; Bagadiya A; Makwana S; Vipul V; Batt D; Dharamsi A
    J Adv Pharm Technol Res; 2011 Oct; 2(4):266-73. PubMed ID: 22247895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term stability of epinephrine sublingual tablets for the potential first-aid treatment of anaphylaxis.
    Rawas-Qalaji MM; Rachid O; Simons FE; Simons KJ
    Ann Allergy Asthma Immunol; 2013 Dec; 111(6):568-70. PubMed ID: 24267371
    [No Abstract]   [Full Text] [Related]  

  • 23. Formulation and characterization of oral rapid disintegrating tablets of levocetirizine.
    Samvedna S; Jindal S; Mishra G; Madan JR; Gupta G; Awasthi R; Pinto TJA; Dua K; Kulkarni GT
    Polim Med; 2018; 48(1):31-40. PubMed ID: 30657656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: evaluation of wetting and disintegration of tablet on the basis of surface free energy.
    Fukami J; Ozawa A; Yoshihashi Y; Yonemochi E; Terada K
    Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1536-9. PubMed ID: 16327184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C; Prabhakar B
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation.
    Rahman Z; Siddiqui A; Khan MA
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1300-9. PubMed ID: 23800704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
    Fukami J; Yonemochi E; Yoshihashi Y; Terada K
    Int J Pharm; 2006 Mar; 310(1-2):101-9. PubMed ID: 16434157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
    Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fabrication and optimization of fast disintegrating tablets employing interpolymeric chitosan-alginate complex and chitin as novel superdisintegrants.
    Goel H; Tiwary AK; Rana V
    Acta Pol Pharm; 2011; 68(4):571-83. PubMed ID: 21796940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and evaluation of sublingual tablets of zolmitriptan.
    Prajapati ST; Patel MV; Patel CN
    Int J Pharm Investig; 2014 Jan; 4(1):27-31. PubMed ID: 24678459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations.
    Bejugam NK; Mutyam SK; Shankar GN
    Drug Dev Ind Pharm; 2015 Feb; 41(2):333-41. PubMed ID: 24279424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of epinephrine sublingual stability and permeability pathways to enhance its permeability for the treatment of anaphylaxis.
    Rawas-Qalaji M; Bafail R; Cagliani R; Haider M; Hussain Z
    Eur J Pharm Sci; 2021 Dec; 167():106025. PubMed ID: 34600046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Casale TB; Lockey RF; Fogh BS; Kaur A; Lu S; Nelson HS
    J Allergy Clin Immunol Pract; 2017; 5(1):84-89.e3. PubMed ID: 27838323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
    Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
    Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation Development and Evaluation of Fast Disintegrating Tablet of Cetirizine Hydrochloride: A Novel Drug Delivery for Pediatrics and Geriatrics.
    Sharma D; Singh M; Kumar D; Singh G
    J Pharm (Cairo); 2014; 2014():808167. PubMed ID: 26556203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enalapril maleate orally disintegrating tablets: tableting and in vivo evaluation in hypertensive rats.
    Tawfeek HM; Faisal W; Soliman GM
    Pharm Dev Technol; 2018 Jun; 23(5):496-503. PubMed ID: 28489472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
    Hooper P; Lasher J; Alexander KS; Baki G
    J Pharm Biomed Anal; 2016 Feb; 120():391-6. PubMed ID: 26774944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.